Biography and Research Information
OverviewAI-generated summary
Amisha Fnu's research focuses on hematological conditions and cardiovascular health. She has investigated tandem autologous stem cell transplantation in patients with multiple myeloma, specifically examining its efficacy in cases of persistent minimal residual disease after initial transplantation. Fnu has also contributed to discussions on the treatment of left ventricular thrombi, comparing the use of warfarin with direct oral anticoagulants. Her work has resulted in several publications, and she has a notable collaboration network within the University of Arkansas for Medical Sciences, with multiple shared publications with Manojna Konda, Anusha Jillella, Nishanth Thalambedu, and Sravani Gundarlapalli. Fnu's scholarship metrics include an h-index of 1, with a total of 5 publications and 6 citations.
Metrics
- h-index: 1
- Publications: 5
- Citations: 6
Selected Publications
-
Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075] (2022)
-
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma (2022)
-
WITHDRAWN: How to treat left ventricular thrombi - Warfarin or direct oral anti-coagulants? (2021)
-
How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants? (2021)
Collaboration Network
Top Collaborators
- How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants?
- WITHDRAWN: How to treat left ventricular thrombi - Warfarin or direct oral anti-coagulants?
- Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075]
- How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants?
- WITHDRAWN: How to treat left ventricular thrombi - Warfarin or direct oral anti-coagulants?
- Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075]
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
Similar Researchers
Based on overlapping research topics